Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants. - Wikidata - awgldk - TriplyDB

Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants.

Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants.

http://www.wikidata.org/entity/Q42498205

about

The urgent need to recover MHC class I in cancers for effective immunotherapy Tumour immunology, vaccination and escape strategies The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?Targeting HLA class I expression to increase tumor immunogenicity.Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes.Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype.Rejection versus escape: the tumor MHC dilemma.Immunotherapy eradicates metastases with reversible defects in MHC class I expression.Impact of p53-based immunization on primary chemically-induced tumors.Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.

P2860

Q26770165-E4BC6855-2759-46C9-A64F-1F3A0ADE19AA Q28208633-88AA9BF7-2F26-4AE7-9933-0F5EEE194DBD Q34208784-CE7BB3B0-36A2-4942-A3A2-74056A84DB6C Q36726974-5D115D6F-965F-4CAF-9010-6BD6574BBFD2 Q37981721-21AB3082-9246-42EC-9246-758D8B6E0C77 Q38029543-D6048473-3C4E-4230-85D5-1E6DC79B546F Q38282541-8CF38E2C-11B1-4D28-B758-937F454ACCE1 Q39063943-FF671566-B7E5-406B-AE86-8B8426A9AC76 Q39546174-A013D27D-7051-4155-884C-BF383BE46E08 Q45130509-81AE1FE2-AE0B-48FB-A266-EE27CB579A68 Q53274440-BC779E07-9759-4F96-890D-F6AEF2A82721 Q53662510-4EDD3C19-9103-4F68-8F2B-77FE8F344A97 Q54796511-EA6676D7-742D-44EE-AA8C-C4D1DFF28308

P2860

Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants.

http://www.wikidata.org/entity/Q42498205

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Immunoselection by T lymphocyt ...... ent metastatic tumor variants.

@en

Immunoselection by T lymphocyt ...... ent metastatic tumor variants.

@nl

type

label

Immunoselection by T lymphocyt ...... ent metastatic tumor variants.

@en

Immunoselection by T lymphocyt ...... ent metastatic tumor variants.

@nl

prefLabel

Immunoselection by T lymphocyt ...... ent metastatic tumor variants.

@en

Immunoselection by T lymphocyt ...... ent metastatic tumor variants.

@nl

P1433

Q42498205-92D2ECA9-E57B-476D-88E1-0C8842BD3650

P1476

Q42498205-C3977964-B05F-4587-A6E7-8A0DC9531453

P2093

Q42498205-17368CB0-77E2-44D4-8CBB-E26AB6502C18

Q42498205-7FC0A95E-A55D-4DBA-8AA9-778703BDDE8B

Q42498205-8BA70D55-7377-46FA-8BEC-E6D77D266990

Q42498205-C64B839B-9305-4111-A797-47D105E56AD3

Q42498205-E3029FA5-62D6-479E-BE4D-D86A921CA694

P2860

Q42498205-0F5280DB-6691-4604-B7F4-C80ECA8E2A20

Q42498205-3D8C0893-E570-4FEF-81ED-176DCE9DF20A

Q42498205-417AE287-80BF-42B5-8A58-4C4540C7336E

Q42498205-4CB57600-B6E1-43F7-AC33-61303D75A5AD

Q42498205-4EA945A2-A6C3-49FD-B7B3-BE4FBE5740FE

Q42498205-4F37605C-6682-46D2-AFDB-A6C46971BD3E

Q42498205-4FFE39A4-10AA-4E3F-A93A-D884F7FEFD10

Q42498205-50D1E78F-7DFF-451B-A250-33F96BF6942F

Q42498205-5E5FB471-B776-4A8D-B99B-2E2DB46A54D4

Q42498205-5FA563B7-7041-4B01-8165-1197EFF62001

P304

Q42498205-130A7CF4-6E70-492D-A602-534E0603BB7C

P31

Q42498205-E4FED6F6-A501-4184-9A95-5C795FB5EFDA

P356

Q42498205-AF7C845B-167B-4126-83DC-8C83BAF97B8E

P433

Q42498205-11527B67-2FC4-42AA-A1C9-244C1B849338

P478

Q42498205-66F900A5-23C5-43C2-AD5F-2A4526849628

P577

Q42498205-0C478663-8ACF-4E20-9A53-9380C41FAD72

P698

Q42498205-2E5BAB6D-884A-49E6-B829-54656143C7D3

P356

1097-0215(20010101)91:1%3C109::AID-IJC1017%3E3.0.CO;2-E

P1433

International Journal of Cancer

P1476

Immunoselection by T lymphocyt ...... ent metastatic tumor variants.

@en

P2093

A Garcia-Lora

http://www.w3.org/2001/XMLSchema#string

F Garrido

http://www.w3.org/2001/XMLSchema#string

F Ruiz-Cabello

http://www.w3.org/2001/XMLSchema#string

I Algarra

http://www.w3.org/2001/XMLSchema#string

J J Gaforio

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of human cancers deficient in antigen processing

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story.

The HLA crossroad in tumor immunology.

Molecular basis of the dm1 mutation in the major histocompatibility complex of the mouse: a D/L hybrid gene.

Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells.

Natural history of HLA expression during tumour development.

Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses.

A new beta 2 microglobulin mutation found in a melanoma tumor cell line.

P304

109-119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1097-0215(20010101)91:1<109::AID-IJC1017>3.0.CO;2-E

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11149409

http://www.w3.org/2001/XMLSchema#string